Skip to main content
main-content

Onkologie und Hämatologie | Zeitschrift

memo - Magazine of European Medical Oncology

memo - Magazine of European Medical Oncology 3/2014

Ausgabe 3/2014

Inhaltsverzeichnis ( 17 Artikel )

01.09.2014 | editorial | Ausgabe 3/2014

ASH 2013: constant progress: not only for B-cell neoplasms

Michael Steurer MD

01.09.2014 | editorial | Ausgabe 3/2014

The challenge of soft tissue sarcomas—critical aspects of therapies with curative intent

Dr. Georg Pall

01.09.2014 | short review | Ausgabe 3/2014

Highlights of the American Society of Hematology Meeting 2013: hemostaseology

Clemens Feistritzer MD, Sophie Maria Wildner MD

01.09.2014 | short review | Ausgabe 3/2014

Aggressive lymphoma at ASH 2013: R-CHOP under attack?

Thomas Nösslinger MD

01.09.2014 | short review | Ausgabe 3/2014

Myelodysplastic syndromes (MDS)

Sonja Burgstaller MD

01.09.2014 | short review | Ausgabe 3/2014

ASH 2013: short review on myeloproliferative neoplasms

Stefan Schmidt MD

01.09.2014 | short review | Ausgabe 3/2014

ASH Update 2013: chronic lymphocytic leukemia and indolent lymphoma

Michael Steurer MD

01.09.2014 | short review | Ausgabe 3/2014

Molecular monitoring of minimal residual disease in acute leukemia

Priv-Doz. Mag. Dr. Otto Zach PD, PhD, Johannes Clausen MD

01.09.2014 | short review | Ausgabe 3/2014

Venous thromboembolism in children with acute lymphoblastic leukemia

Jolanta Skalska-Sadowska PhD, Katarzyna Derwich PhD

01.09.2014 | short review | Ausgabe 3/2014

The role of maintenance strategies in breast cancer

Elisabetta Munzone MD, Marco Colleoni MD

01.09.2014 | original report | Ausgabe 3/2014

Clinicopathological profile of bilateral breast cancer at a tertiary cancer center in South India

K. C. Lakshmaiah MD, DM, Umesh Das MD, K. Govind Babu MD, DM, T. M. Suresh MD, DM, D. Lokanatha MD, DM, Linu A. Jacob MD, DM, Suresh Babu MD, DM, Prof. G. Mukherjee, Prof. M. Vijayakumar

01.09.2014 | special report | Ausgabe 3/2014

Challenges with overall survival as an endpoint for efficacy assessment in first line metastatic breast cancer randomized controlled clinical trials and the investigation of truncated overall survival as an alternative endpoint

Colin Neate MSc, Alexander Strasak PhD, Hans Ulrich Burger PhD, Barbara Tong PhD, Lee Kaiser PhD

01.09.2014 | short review | Ausgabe 3/2014

Neoadjuvant chemotherapy for soft tissue sarcoma

Ewald Wöll MD

01.09.2014 | review | Ausgabe 3/2014

Importance of intraoperative radiation therapy in the treatment of soft tissue sarcoma: data at hand

Arpad Sztankay MD

01.09.2014 | short review | Ausgabe 3/2014

Surgical aspects in the treatment of retroperitoneal soft tissue sarcomas

Alexander Perathoner, Reinhold Kafka-Ritsch, Ass.-Prof. Priv.-Doz. Dr. Matthias Zitt

01.09.2014 | special report | Ausgabe 3/2014

Long-term tolerability of the BRAF inhibitor vemurafenib in patients with metastatic melanoma: current study data and real-life observations

Cathrin Balmelli MD, Michael Mark MD, Christian Spirig MD, Vito Spataro MD, Stefanie Pederiva MD, Christian Monnerat MD, Prof. Alfred Zippelius, Andreas Wicki MD, PhD

01.09.2014 | short review | Ausgabe 3/2014

Colorectal cancer: screening and some notes on the prevention

Paul Bergmeister MD, Alois Hermann Lang MD

Aktuelle Ausgaben